COMMUNIQUÉS West-GlobeNewswire

Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
12/03/2024
Keynote Will Discuss Cellular Immunotherapy’s Potential for Treating Chronic Conditions, Including Cancer, Multiple Sclerosis and Parkinson’s Disease FLORHAM PARK, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Celularity Inc [...]
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
12/03/2024
ART26.12 Preclinical Dermatology Research Presented to the Immuno-dermatology Leadership Team at Johnson & Johnson SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a [...]
Sharecare provides strategic update
12/03/2024
Independent special committee of the Sharecare Board of Directors reviewing multiple proposals ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ) has been evaluating a range of options including a [...]
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
12/03/2024
Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screening Southlake, Texas, March 12, 2024 (GLOBE NEWSWIRE [...]
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
12/03/2024
HeartFlow's non-invasive AI driven FFR CT predicts patient outcomes as effectively as the gold-standard invasive FFR out to 10 years MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in [...]
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
12/03/2024
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Nasdaq [...]
Sharecare reschedules issuance of fourth quarter and full year 2023 earnings release and investor conference call
12/03/2024
ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced that it has postponed the release of its [...]
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
12/03/2024
The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market Dallas, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals [...]
Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initiate First Clinical Trial of AT-001 (NPI-001) for the Treatment of HCCAA
12/03/2024
EMA approved clinical trial of AT-001 (NPI-001) in Iceland REYKJAVIK, Iceland and FORT WORTH, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Arctic Therapeutics ehf, an Icelandic drug development company and partner Nacuity [...]
Solera and Aon Collaborate to Offer Employers Curated Network of Digital Health Solutions and Analytics for Clinical Outcomes and Cost Savings
12/03/2024
Collaboration provides personalized employee health experiences and optimized outcomes across the most common chronic conditions - delivering a streamlined solution PHOENIX, March 12, 2024 (GLOBE NEWSWIRE) -- Solera [...]
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
12/03/2024
-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month -- -- Study will evaluate the use of Portable Neuromodulation Stimulator (PoNS®) for gait and balance deficits in chronic stroke [...]
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
12/03/2024
– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average – Findings demonstrate real-world [...]
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
12/03/2024
Data provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control. The human GLP-1 [...]
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
12/03/2024
– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April – – Phase 1 trial of INZ-701 in end-stage kidney disease (ESKD) patients receiving [...]
Fortress Biotech to Participate in 36th Annual ROTH Conference
12/03/2024
MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing [...]
Roche Annual General Meeting 2024
12/03/2024
All proposals of the Board of Directors approved Severin Schwan re-elected as Chairman of the Board of Directors; all other Board members standing for election confirmed 37th consecutive dividend increase to CHF 9.60 [...]
Assemblée générale 2024 de Roche
12/03/2024
Adoption de toutes les propositions du Conseil d’administration Réélection de Severin Schwan à la présidence du Conseil d’administration ; confirmation de tous les autres membres du Conseil d’administration qui se sont [...]
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
12/03/2024
Allogene’s AlloCAR T™ Autoimmune Disease Platform Leverages Arbor’s CRISPR Gene-Editing Technology First Allogeneic CAR T Phase 1 Clinical Trial in Autoimmune Disease Expected to Initiate in Early 2025 SOUTH SAN [...]
Tenax Therapeutics to Present at the 36th Annual Roth Conference
12/03/2024
CHAPEL HILL, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that [...]

Pages